Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 22, 2026

Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function
09:40

Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function

Published on: July 29, 2021

Organoids: From Bench to Bedside Applications.

Kelin Li1, Rui Cao2, Maochen Li1

  • 1College of Life Science and Technology Beijing University of Chemical Technology Beijing China.

Medcomm
|May 21, 2026
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized controlled trials of major oral traditional Chinese medicine preparations for postherpetic neuralgia: an evidence map.

Frontiers in pharmacology·2026
Same author

LASSO regression-based machine learning model for differentiating spinal tuberculosis, pyogenic spondylitis, and endplate osteochondritis: development and clinical application.

Frontiers in cellular and infection microbiology·2026
Same author

Exploring the dominant endophytic pleosporalean fungi in <i>Poaceae</i> plants: taxonomic novelties within the suborder <i>Massarineae</i>.

Mycology·2026
Same author

Purpose in Later Life: The Role of Subjective Aging.

International journal of aging & human development·2026
Same author

Toward the precision use of Chinese PARP inhibitors in ovarian cancer: clinical progress, resistance mechanisms, and future perspectives.

Cancer biology & medicine·2026
Same author

Concordant Women, Infants, and Children Staff and Pediatrician Recommendations Associated with Improved Breastfeeding.

The Journal of nutrition·2026
Same journal

Development and Validation of a Pathomics Model for Prognosis Prediction in Neoadjuvant Therapy-Treated Breast Cancer: A Retrospective, Multicenter Study.

MedComm·2026
Same journal

Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy.

MedComm·2026
Same journal

Osimertinib Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Mechanisms and Therapeutic Strategies.

MedComm·2026
Same journal

Epilepsy: Epidemiology, Molecular Pathogenesis, and Clinical Management.

MedComm·2026
Same journal

Metabolic Dysfunction-Associated Fatty Liver Disease: From Pathogenesis to Treatment.

MedComm·2026
Same journal

Dexmedetomidine Rapidly Relieves Stress-Induced Hyperalgesia via Presynaptic <i>α</i>2-Adrenergic Inhibition at Orbitofrontal-Insular Glutamatergic Synapses.

MedComm·2026
See all related articles

Organoid models offer advanced 3D platforms for studying human tissues and virus-host interactions. This review highlights organoid advancements in virology, disease modeling, and drug development, paving the way for translational medicine.

Area of Science:

  • Biomedical Research
  • Virology
  • Stem Cell Technology

Background:

  • Organoids are 3D stem cell-derived models mimicking human tissue structure and complexity.
  • They overcome limitations of 2D cultures, offering physiologically relevant platforms for research.
  • Organoids are crucial for studying virus-host interactions and pathogenesis under near-physiological conditions.

Purpose of the Study:

  • To review key advancements in organoid-based virology.
  • To explore organoid applications in disease modeling (cancer, neurological disorders) and drug development.
  • To discuss integration with emerging technologies and propose strategies for broader adoption.

Main Methods:

  • Systematic review of organoid technology in virology and disease modeling.
Keywords:
organoidspathogenesisstem cells

More Related Videos

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
07:31

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on: May 26, 2023

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on: September 15, 2023

Related Experiment Videos

Last Updated: May 22, 2026

Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function
09:40

Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function

Published on: July 29, 2021

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
07:31

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on: May 26, 2023

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on: September 15, 2023

  • Analysis of organoid utility for culturing difficult pathogens (e.g., HRV-C, NoV).
  • Examination of organoid applications in studying viral infections (e.g., SARS-CoV-2, ZIKV) and antiviral screening.
  • Main Results:

    • Organoids enable propagation of hard-to-culture viruses and provide insights into viral pathogenesis.
    • Successful modeling of SARS-CoV-2 and ZIKV infections using organoid systems.
    • Demonstrated translational utility for antiviral drug screening and preclinical assessments.

    Conclusions:

    • Organoid technology significantly advances biomedical research, particularly in virology and disease modeling.
    • Integration with technologies like CRISPR and 3D bioprinting holds immense potential.
    • Addressing challenges like immune component inclusion and vascularization will accelerate organoid adoption in translational medicine.